Molecular modeling of novel 2-aminopyridine derivatives as potential JAK2 inhibitors: a rational strategy for promising anticancer agents

References

• Ali, A., Khan, M. T., Khan, A., Ali, S., Chinnasamy, S., Akhtar, K., Shafiq, A., Wei, D.-Q., & J., R. A (2020). Pyrazinamide resistance of novel mutations in pncA and their dynamic behavior. RSC Advances, 10(58), 35565–35573. https://doi.org/10.1039/d0ra06072k
   PubMed Web of Science ®Google Scholar
• Arantes, P. R., Polêto, M. D., Pedebos, C., & Ligabue-Braun, R. J. J. O C. I. (2021). Modeling, making it rain: Cloud-based molecular simulations for everyone. Journal of Chemical Information and Modeling, 61(10), 4852–4856. https://doi.org/10.1021/acs.jcim.1c00998
   PubMed Web of Science ®Google Scholar
• Ayele, T. M., Muche, Z. T., Teklemariam, A. B., Kassie, A. B., & Abebe, E. C. (2022). Role of JAK2/STAT3 signaling pathway in the tumorigenesis, chemotherapy resistance, and treatment of solid tumors. A Systemic Review. Journal of Inflammation Research, 15, 1349.
   PubMed Web of Science ®Google Scholar
• Babu, S., Nagarajan, S. K., & Madhavan, T. (2019). Understanding the structural features of JAK2 inhibitors: A combined 3D-QSAR, DFT and molecular dynamics study. Molecular Diversity, 23(4), 845–874. https://doi.org/10.1007/s11030-018-09913-4
   PubMed Web of Science ®Google Scholar
• Balupuri, A., Balasubramanian, P. K., & Cho, S. J. (2020). 3D-QSAR, docking, molecular dynamics simulation and free energy calculation studies of some pyrimidine derivatives as novel JAK3 inhibitors. Arabian Journal of Chemistry, 13(1), 1052–1078. https://doi.org/10.1016/j.arabjc.2017.09.009
   Web of Science ®Google Scholar
• Ban, T., Ohue, M., & Akiyama, Y. J. C. B (2018). Chemistry, multiple grid arrangement improves ligand docking with unknown binding sites: Application to the inverse docking problem. Computational Biology and Chemistry, 73, 139–146. https://doi.org/10.1016/j.compbiolchem.2018.02.008
   PubMed Web of Science ®Google Scholar
• Buggana, S. J., Paturi, M. C., Perka, H., Gade, D. R., & Vvs, R. P. (2019). Novel 2, 4-disubstituted quinazolines as cytotoxic agents and JAK2 inhibitors: Synthesis, in vitro evaluation and molecular dynamics studies. Computational Biology and Chemistry, 79, 110–118. https://doi.org/10.1016/j.compbiolchem.2019.01.008
   PubMed Web of Science ®Google Scholar
• Chen, S.-F., Cao, Y., Chen, J.-J., & Chen, J.-Z J. J. O M M (2013). Binding selectivity studies of PKBα using molecular dynamics simulation and free energy calculations. Journal of Molecular Modeling, 19(11), 5097–5112. https://doi.org/10.1007/s00894-013-1997-3
   PubMed Web of Science ®Google Scholar
• Chohan, T. A., Chen, J.-J., Qian, H.-Y., Pan, Y.-L., & Chen, J.-Z. (2016). Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations. Molecular bioSystems, 12(4), 1250–1268. https://doi.org/10.1039/c5mb00860c
   PubMedGoogle Scholar
• Garg, A., Goel, N., Abhinav, N., Varma, T., Achari, A., Bhattacharjee, P., Kamal, I. M., Chakrabarti, S., Ravichandiran, V., Reddy, A. M., Gupta, S., & Jaisankar, P. (2023). Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease. Journal of Biomolecular Structure and Dynamics, 41(5), 2033–2045. https://doi.org/10.1080/07391102.2022.2027271
   Google Scholar
• Kakarala, K. K., Jamil, K. J., J., O., R., & Transduction, S. (2015). Screening of phytochemicals against protease activated receptor 1 (PAR1), a promising target for cancer. Journal of Receptor and Signal Transduction Research, 35(1), 26–45. https://doi.org/10.3109/10799893.2014.926925
   PubMed Web of Science ®Google Scholar
• Keretsu, S., Bhujbal, S. P., & Cho, S. J. J. B. O T K. C. S. (2020). Computational study of pyrimidin‐2‐aminopyrazol‐hydroxamate‐based jak2 inhibitors for the treatment of myeloproliferative neoplasms. Bulletin of the Korean Chemical Society, 41(5), 542–551. https://doi.org/10.1002/bkcs.12008
   Web of Science ®Google Scholar
• Liu, D., Ge, H., Xu, F., Xu, Y., Liu, W., Li, H., Zhu, L., Diao, Y., & Zhao, Z. (2022). Design, synthesis and SAR study of 2-aminopyridine derivatives as potent and selective JAK2 inhibitors. Chinese Chemical Letters, 33(6), 2969–2974. https://doi.org/10.1016/j.cclet.2021.12.099
   Web of Science ®Google Scholar
• Ma, X., Diao, Y., Ge, H., Xu, F., Zhu, L., Zhao, Z., & Li, H. (2020). Discovery and optimization of 2-aminopyridine derivatives as novel and selective JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters, 30(8), 127048. https://doi.org/10.1016/j.bmcl.2020.127048
   PubMed Web of Science ®Google Scholar
• Mittal, L., Kumari, A., Srivastava, M., Singh, M., & Asthana, S. J. J. O B. S. (2021). Dynamics, identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach. Journal of Biomolecular Structure & Dynamics, 39(10), 3662–3680. https://doi.org/10.1080/07391102.2020.1768151
   PubMed Web of Science ®Google Scholar
• Raza, A., Chohan, T. A., Sarfraz, M., Chohan, T. A., Imran Sajid, M., Tiwari, R. K., Ansari, S. A., Alkahtani, H. M., Yasmeen Ansari, S., Khurshid, U., & Saleem, H. (2023). Molecular modeling of pyrrolo-pyrimidine based analogs as potential FGFR1 inhibitors: A scientific approach for therapeutic drugs. Journal of Biomolecular Structure and Dynamics, 41(23), 14358–14371. https://doi.org/10.1080/07391102.2023.2187638
   Google Scholar
• Thakur, A., Patwa, J., Pant, S., Sharma, A., & Flora, S. R J. S. R. (2021). Interaction study of monoisoamyl dimercaptosuccinic acid with bovine serum albumin using biophysical and molecular docking approaches. Scientific Reports, 11(1), 1–14.
   PubMed Web of Science ®Google Scholar
• Wang, W., Diao, Y., Li, W., Luo, Y., Yang, T., Zhao, Y., Qi, T., Xu, F., Ma, X., Ge, H., Liang, Y., Zhao, Z., Liang, X., Wang, R., Zhu, L., Li, H., & Xu, Y. (2019). Design, synthesis and structure-activity relationship study of aminopyridine derivatives as novel inhibitors of Janus kinase 2. Bioorganic & Medicinal Chemistry Letters, 29(12), 1507–1513. https://doi.org/10.1016/j.bmcl.2019.04.011
   PubMed Web of Science ®Google Scholar
• Wang, Y., Huang, W., Xin, M., Chen, P., Gui, L., Zhao, X., Tang, F., Wang, J., & Liu, F. (2017). Identification of 4-(2-furanyl) pyrimidin-2-amines as Janus kinase 2 inhibitors. Bioorganic & Medicinal Chemistry, 25(1), 75–83. https://doi.org/10.1016/j.bmc.2016.10.011
   PubMed Web of Science ®Google Scholar
• Wang, Y., Huang, W., Xin, M., Chen, P., Gui, L., Zhao, X., Zhu, X., Luo, H., Cong, X., Wang, J., & Liu, F. (2019). Discovery of potent anti-inflammatory 4-(4, 5, 6, 7-tetrahydrofuro [3, 2-c] pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors. Bioorganic & Medicinal Chemistry, 27(12), 2592–2597. https://doi.org/10.1016/j.bmc.2019.03.048
   PubMed Web of Science ®Google Scholar
• Yang, T., Hu, M., Chen, Y., Xiang, M., Tang, M., Qi, W., Shi, M., He, J., Yuan, X., Zhang, C., Liu, K., Li, J., Yang, Z., & Chen, L. (2020). N-(Pyrimidin-2-yl)-1, 2, 3, 4-tetrahydroisoquinolin-6-amine derivatives as selective Janus kinase 2 inhibitors for the treatment of myeloproliferative neoplasms. Journal of Medicinal Chemistry, 63(23), 14921–14936. https://doi.org/10.1021/acs.jmedchem.0c01488
   PubMed Web of Science ®Google Scholar